"Sirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better?." Leukemia & Lymphoma, 56(3), pp. 555–556
Potential conflict of interest:
Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.